<?xml version="1.0" encoding="UTF-8"?>
<p id="p0140">Morbidity was evaluated on a 1 to 5 scale shown in 
 <xref rid="f0025" ref-type="fig">Fig. 5</xref>b. The VLP- and VLP + alum-induced immune sera delivered neat, in addition to ZKA190 mAb, protected the AG129 mice against ZIKV-induced morbidity. An increase in morbidity was evident around Day 12 following ZIKV challenge for the VLP-induced sera (diluted 1:5), VLP + alum-induced sera (diluted 1:5), Alum, and Naïve groups.
</p>
